Mr. Lee Yong Qian ("Mr. Lee") was appointed to the Board on 16 September 2024 and served as the Alternate Director to Dato' Dr. Lee Gaik Cheng and Strategic Director, before his appointment as the Executive Director on 3 June 2026. He is responsible for the corporate affairs, coordinating the sharing of information between the medical and non-medical departments as well as overseeing the preparation of corporate policies.

He graduated with a Bachelor of Arts with Major in Political Economy from the University of California, Berkeley, United States of America, in 2022.

In July 2022, he commenced his career in M&A Securities Sdn Bhd ("M&A"), a wholly-owned subsidiary of M&A Equity Holdings Berhad, a company listed on the Main Market of Bursa Malaysia Securities Berhad, as an intern. In October 2022, he was employed as an Executive in Corporate Finance department, where he was responsible for researching and drafting relevant documents in connection to initial public offering exercises. In January 2024, he was promoted to Senior Executive and continued in that role until his resignation in March 2024.

Subsequently, he joined PMCK Group in April 2024 as the Strategic Director, where he assumed his current responsibilities.

Nil

Mr. Lee is the son of Dato' Dr. Lee Gaik Cheng, the Managing Director of the Company.

Nil

Direct Interest: 1,130,000 ordinary shares